148 related articles for article (PubMed ID: 21884211)
41. [Sentinel lymph node biopsy in patients with melanoma].
Tomás-Mallebrera L; Rojo-España R; Marquina-Vila A; Gimeno-Clemente N; Morales-Suárez-Varela MM
Actas Dermosifiliogr; 2010 Jun; 101(5):428-36. PubMed ID: 20525486
[TBL] [Abstract][Full Text] [Related]
42. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
[TBL] [Abstract][Full Text] [Related]
43. Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.
van Lanschot CG; Koljenović S; Grunhagen DJ; Verhoef C; van Akkooi AC
Melanoma Res; 2014 Jun; 24(3):261-6. PubMed ID: 24608184
[TBL] [Abstract][Full Text] [Related]
44. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
45. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.
Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A
Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975
[TBL] [Abstract][Full Text] [Related]
46. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
47. Vulvar melanoma: is there a role for sentinel lymph node biopsy?
de Hullu JA; Hollema H; Hoekstra HJ; Piers DA; Mourits MJ; Aalders JG; van der Zee AG
Cancer; 2002 Jan; 94(2):486-91. PubMed ID: 11905414
[TBL] [Abstract][Full Text] [Related]
48. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
49. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
50. Reliability of sentinel lymph node biopsy for staging melanoma.
Jansen L; Nieweg OE; Peterse JL; Hoefnagel CA; Olmos RA; Kroon BB
Br J Surg; 2000 Apr; 87(4):484-9. PubMed ID: 10759748
[TBL] [Abstract][Full Text] [Related]
51. Sentinel lymph node biopsy and melanoma biology.
Essner R
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
[TBL] [Abstract][Full Text] [Related]
52. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.
Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R
J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338
[TBL] [Abstract][Full Text] [Related]
53. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients.
van der Ploeg AP; van Akkooi AC; Haydu LE; Scolyer RA; Murali R; Verhoef C; Thompson JF; Eggermont AM
Eur J Cancer; 2014 Jan; 50(1):111-20. PubMed ID: 24074765
[TBL] [Abstract][Full Text] [Related]
54. The predictive power of serum S-100B for non-sentinel node positivity in melanoma patients.
Damude S; Hoekstra HJ; Bastiaannet E; Muller Kobold AC; Kruijff S; Wevers KP
Eur J Surg Oncol; 2016 Apr; 42(4):545-51. PubMed ID: 26831006
[TBL] [Abstract][Full Text] [Related]
55. Is 1 mm thickness sec. Breslow the correct cut-off for sentinel node biopsy in melanoma? Report of six cases of metastasis by thin melanoma.
Quarto G; Sivero L; Benassai G; Bucci L; Desiato V; Perrotta S; Benassai G; Massa S
Ann Ital Chir; 2013; 84(5):575-8. PubMed ID: 24141056
[TBL] [Abstract][Full Text] [Related]
56. Sentinel node biopsy in melanoma: Current controversies addressed.
Madu MF; Wouters MW; van Akkooi AC
Eur J Surg Oncol; 2017 Mar; 43(3):517-533. PubMed ID: 27590685
[TBL] [Abstract][Full Text] [Related]
57. How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma.
Mijnhout GS; Hoekstra OS; van Lingen A; van Diest PJ; Adèr HJ; Lammertsma AA; Pijpers R; Meijer S; Teule GJ
J Clin Pathol; 2003 Apr; 56(4):283-6. PubMed ID: 12663640
[TBL] [Abstract][Full Text] [Related]
58. Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients.
Voit CA; Gooskens SL; Siegel P; Schaefer G; Schoengen A; Röwert J; van Akkooi AC; Eggermont AM
Eur J Cancer; 2014 Sep; 50(13):2280-8. PubMed ID: 24999208
[TBL] [Abstract][Full Text] [Related]
59. Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study.
Riber-Hansen R; Hastrup N; Clemmensen O; Behrendt N; Klausen S; Ramsing M; Spaun E; Hamilton-Dutoit SJ; Steiniche T
Eur J Cancer; 2012 Feb; 48(3):347-52. PubMed ID: 22023888
[TBL] [Abstract][Full Text] [Related]
60. Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.
Belgrano V; Katsarelias D; Mattsson J; Olofsson Bagge R
Eur J Surg Oncol; 2019 Feb; 45(2):225-230. PubMed ID: 30391091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
